NAUT

Nautilus Biotechnology (NAUT)

About Nautilus Biotechnology (NAUT)

Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Details

Daily high

$2.08

Daily low

$1.97

Price at open

$2.03

52 Week High

$2.54

52 Week Low

$0.62

Market cap

256.4M

Dividend yield

0.00%

Volume

154,332

Avg. volume

197,196

P/E ratio

-4.07

Nautilus Biotechnology News